Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,033,682
-$125,909 QoQ
Shares Held
42,927
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,311
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $20,079,575 across 8 Drug Manufacturers - General names. PFE ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,238 | $8,681,475 | |
| 2 | JNJ |
Johnson & Johnson
|
22,094 | $5,611,213 | |
| 3 | ABBV |
AbbVie Inc.
|
9,774 | $2,459,529 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,797 | $1,130,414 | |
| 5 | PFE |
Pfizer Inc
This page
|
42,927 | $1,033,682 | |
| 6 | AMGN |
Amgen Inc
|
1,326 | $480,171 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,527 | $376,085 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,430 | $307,006 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,033,682 | 42,927 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,159,591 | 41,296 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,040,571 | 41,790 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,010,740 | 39,668 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $867,452 | 35,786 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $894,248 | 35,290 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $671,925 | 25,327 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $833,906 | 28,815 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $783,579 | 28,005 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $862,109 | 31,067 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $873,200 | 30,330 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $995,265 | 30,005 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,179,298 | 32,151 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $755,371 | 18,514 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $885,427 | 17,280 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $831,702 | 19,006 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $962,667 | 18,361 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $920,832 | 17,787 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,009,577 | 17,097 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $532,205 | 12,374 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $303,176 | 7,742 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $296,687 | 8,189 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $268,344 | 7,290 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $260,606 | 7,101 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $206,500 | 6,315 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $220,384 | 6,752 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||